Evidence map›Paper›PMID 38047647›Full record

ArticlemSystems2023

Repurposing of the antimalarial agent tafenoquine to combat MRSA.

Pengfei She, Yifan Yang, Linhui Li, Yimin Li, Shasha Liu, Zehao Li, Linying Zhou, Yong Wu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSystems, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Drug Repurposing: An Emerging Strategy inJournal of microbiology and biotechnology · 2025
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Pengfei She *Department of Laboratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
Yifan Yang *Department of Laboratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
Linhui LiDepartment of Laboratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
Yimin LiDepartment of Laboratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
Shasha LiuDepartment of Laboratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
Zehao LiDepartment of Laboratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
Linying ZhouDepartment of Laboratory Medicine, The Affiliated Changsha Hospital of Xiangya School of Medicine (The First Hospital of Changsha), Central South University, Changsha, China.
Yong WuDepartment of Laboratory Medicine, The Affiliated Changsha Hospital of Xiangya School of Medicine (The First Hospital of Changsha), Central South University, Changsha, China.ORCID 0000-0002-3667-8716
Central South University · CN

Funding

HSTD | Natural Science Foundation of Hunan Province () 2022JJ70046Key Research and Development Program of Hunan Province of China () 2022SK2116MOST | National Natural Science Foundation of China (NSFC) 82072350, 82202591Project of Scientific Research Plan of Hunan Provincial Health Commission B202311000022
6 · The paper itself

Abstract

importanceThis study represents the first investigation into the antimicrobial effect of TAF against

Indexed as

Anti-Infective AgentsAntimalarialsMethicillin-Resistant Staphylococcus aureusAminoquinolinesAnimalsDrug RepositioningMiceStaphylococcus aureusAminoquinolinesAnti-Infective AgentsAntimalarialstafenoquineantimicrobial agentsdrug repurposingmethicillin-resistant Staphylococcus aureustafenoquine

Identifiers

PMID38047647
PMCPMC10734505
OpenAlexW4389306017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.